welcome
The Motley Fool

The Motley Fool

Health

Health

Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022

The Motley Fool
Summary
Nutrition label

71% Informative

Shares of Moderna (NASDAQ: MRNA) slid 31.8% in the first three months of the year .

The vaccine maker's sales continue to struggle years after its top line exploded during the COVID-19 pandemic.

The company's revenues have cratered now that the coronavirus pandemic no longer rages.

VR Score

70

Informative language

71

Neutral language

7

Article tone

semi-formal

Language

English

Language complexity

45

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.